Our product evaluation lab received one bipolar pacing catheter with attached non-ew syringe.Monoject 1.3 cc limited volume syringe was not returned.Clotted blood was observed from the catheter.Continuity testing confirmed a full open condition of the proximal circuit.The distal circuit was found to be continuous.A cut down of the catheter body was performed just proximal of the proximal electrode to expose the pacing leadwires.It was observed that the proximal leadwire was broken at 2.5 cm proximal from catheter tip.It was also confirmed that the proximal circuit was continuous from the broken leadwire to proximal connector pin.The balloon inflated clear and concentric with 1.3 cc air and remained inflated for 5 minutes without leakage.No visible damage or defect was observed from the balloon, windings, and catheter body.A device history record review was initiated to assess that the device met all specifications upon distribution.The customer report of pacing issue was confirmed.An engineering evaluation has been initiated to assess for any manufacturing-related processes which could be correlated to the complaint.A supplemental report will be submitted if there are any findings.Complaint histories for all reported events are reviewed against trending control limits, and any excursions above the control limits are assessed and documented as part of this monthly review.
|
A supplemental mdr is being submitted due to the engineering evaluation findings and device history review.Sections g6, h2 and h6 - type of investigation findings, investigation findings and investigation conclusions have been updated.A device history record review was completed and documented that the device met all specifications upon distribution.An engineering evaluation was initiated to assess for any manufacturing related processes which could be correlated to the complaint.A product risk assessment was previously generated to cover the short condition for bipolar pacing catheters for product nonconformance with moderate, major, or critical severity.Additionally, a capa was generated to address the pacing difficulty failure effect for bipolar products with full open, intermittent, and short conditions and is in the implementation phase.The root cause was related to manufacturing.Complaint histories for all reported events are reviewed against trending control limits, and any excursions above the control limits are assessed and documented as part of this monthly review.
|